Table 2.

Neutralizing antibodies among cases and controls vaccinated with the BNT162b2 CoV-19 vaccine

Variables	WM(n = 90)	Controls(n = 174)	P
NAb, day 1 (%)	15 ± 1.7	16.6 ± 1	.37
NAb, day 22 (%)	28.2 ± 2.5	41.3 ± 1.8	<.001
NAb, day 50 (%)	52 ± 4.3	87.4 ± 1.3	<.001
Percentage over 30% NAb, day 1	10%	11.8%	.66
Percentage over 30% NAb, day 22	37.8%	67.5%	<.001
Percentage over 50% NAb, day 22	16.7%	33.1%	.005
Percentage over 30% NAb, day 50	68.9%	97.7%	<.001
Percentage over 50% NAb, day 50	50.8%	94.3%	<.001

Values are expressed as median ± IQR or as percentages (%). Bold values denote statistical significance.